PUBLISHER: Grand View Research | PRODUCT CODE: 1631504
PUBLISHER: Grand View Research | PRODUCT CODE: 1631504
The U.S. & Europe ambulatory surgery centers market size is estimated to reach USD 157.8 billion by 2030, registering to grow at a CAGR of 6.2% from 2025 to 2030 according to a new report by Grand View Research, Inc. Cost-effectiveness with improved outcomes, increased coverage, technological advancements, and rising acceptance of minimally invasive techniques at the ambulatory surgery centers (ASCs) are the major factors driving the market growth.
The development of advanced surgical systems and diagnostic techniques, which are readily available for ASCs, has reduced the need for hospital admissions. For instance, Intuitive Surgical launched a surgical robotic system named Da Vinci System in 2019 for minimally invasive surgeries for several indications.
Orthopedics accounted for the largest share of 26.7% in 2024. Improving diagnostic methods and imaging technologies in orthopedic surgeries, the introduction of new products, a rise in the number of acquisitions, and favorable reimbursement scenarios are likely to boost the market in the coming years.
The otolaryngology segment is anticipated to expand at the highest CAGR over the forecast period in the U.S. ASC market attributed to the rising number of ENT surgeries in the ASCs. In U.S., around 9% of the total otolaryngology cases are performed in the ambulatory surgery centers.
The physician-owned held the major market share in the ownership segment in the U.S. ambulatory surgery center market in 2019 due to shifting physicians' interest towards freestanding ASCs for increased profitability. In Europe, the hospital-owned dominated the ownership segment owing to the fact that the majority of these facilities are associated with the hospitals.